Article
Development of Novel Inhibitors Targeting Intracellular Steps of Peptidoglycan Biosynthesis
26 Jul 2007
Abstract excerpt
The widespread emergence of pathogenic bacterial strains with resistance to antibiotics is becoming a serious threat to public health. Continuous development of novel antibacterials therefore remains one of the biggest challenges to science and unmet needs in the clinics. The biosynthetic pathway of bacterial peptidoglycan, an essential building block of cell walls, has been well studied and appears to be a rich...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
